Charles L. Sawyers
Founder & Member of Scientific Advisory BoardDr. Charles L. Sawyers, B.A., M.D., Ph.D., is Independent Non Executive Director of BeOne Medicines AG from June 11, 2026 and was its Member of Scientific Advisory Board since 2025. Dr. Sawyers was Member of Scientific Advisory Board of BeOne Medicines AG from April 2021. He is also the Chairman and Inaugural Director of the Human Oncology and Pathogenesis Program (HOPP) at Memorial Sloan-Kettering Cancer Center, a role he has held since 2006. He is also an Investigator of the Howard Hughes Medical Institute and a professor of medicine and of cell and developmental biology at the Weill Cornell Graduate School of Medical Sciences since 2011. He is a Science Partner of The Column Group, LLC. Dr. Sawyers is the Founder of ORIC Pharmaceuticals and serves as a Member of its Scientific Advisory Board. He also founded Seragon Pharmaceuticals Inc. and co-founded Agensys, Inc. He co-founded Aragon Pharmaceuticals, Inc. and served as its Scientific Advisor. He is a Co-Founder of Housey Pharmaceutical Research Laboratories LLC. and Blueprint Medicines Corporation and serves as a Member of their Scientific Advisory Boards. He serves on the Scientific Advisory Boards of numerous other companies, including Nilo Therapeutics, CellCarta, Foghorn Therapeutics Inc. and Petra Pharma Corporation since July 2017. He also serves as a Scientific Advisor for Boston Millennia Partners and KSQ Therapeutics Inc. He served as an Independent Non-Executive Director at Novartis AG from 2013 until March 2025 and as a Senior Advisor at Arsenal Capital Management LP until November 2024. He served as President of the American Association for Cancer Research from 2013 to 2014 and is a past President of the American Society of Clinical Investigation. He was a Member of the US National Cancer Advisory Board from 2012 to 2020. His prior advisory roles include serving on the Scientific Advisory Boards of TRACON Pharmaceuticals, Inc. until 2019, Agios Pharmaceuticals, Inc. since 2009 and PMV Pharmaceuticals, Inc. until 2024. He previously spent nearly two decades at the University of California, Los Angeles (UCLA), where he was a Peter Bing Professor. Dr. Sawyers' work has been recognized with numerous honors, including the 2009 Lasker-DeBakey Clinical Medical Research Award and the Breakthrough Prize in Life Sciences. He completed a Residency in Internal Medicine at the University of California, San Francisco and a Fellowship at the UCLA School of Medicine. He holds an M.D. from The Johns Hopkins University School of Medicine and a B.A. from Princeton University. He also holds a Ph.D.
Positions
- Company NameORIC Pharmaceuticals, Inc.Stock CodeORICPositionFounder & Member of Scientific Advisory BoardColleagues
- RARichard A. HeymanFounder, Independent Chairman & Member of Scientific Advisory Board
- JMJacob M. ChackoPresident, CEO & Director
- DGDominic G. PiscitelliChief Financial Officer
- PSPratik S. MultaniChief Medical Officer
- SWScott W. LoweFounder & Member of Scientific Advisory Board
- MCMardi C. DierIndependent Director
